Abstract
Program Description: Transoral robotic head and neck surgery (TORS) has quickly become an accepted alternative approach for treatment of tumors of the upper aerodigestive tract. Specifically, approaches to oropharyngeal tumors have traditionally been through a mandibulotomy or lingual release approach with its associated postoperative morbidity. Because of this potential morbidity and the proven efficacy of chemoradiotherapy, there has been a paradigm shift away from upfront surgical management. With the advent of TORS over the past few years, several reports have documented its safety and improved functional outcomes in the management not only of oropharyngeal tumors but also of hypopharyngeal and laryngeal cancers without sacrificing tumor control or overall survival. As the indications for TORS continue to expand, will there then be an evolving role for robotic-assisted reconstructive surgery? And what are the indications for reconstructions after TORS? The miniseminar will be composed of four parts: First, the moderator will provide a short introduction. The second speaker will review the current literature and their experience with TORS. They will specifically discuss the current indications and functional results without reconstruction. The third speaker will discuss the rationale for robotic free flap reconstruction, its indications and potential improved function. The last speaker will discuss the current research on robotic assisted reconstruction and its future advantages and challenges ahead.
Educational Objectives: 1) Understand the role of transoral robotic surgery in head and neck cancer. 2) Understand the current use of robotic reconstructive surgery. 3) Understand the indications and future potential for robotic-assisted reconstructive surgery.
Get full access to this article
View all access options for this article.